Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide Glucagon Response in T2D
NCT02020629Phase 4Completed
- Sponsor
- Lund University
- Start
- Dec 2013
- Primary completion
- Aug 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Lund University. Started Dec 2013; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02020629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020629.